XML 133 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Cash and Marketable Securities by Significant Investment Category (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Compensating Balances [Line Items]    
Adjusted Cost $ 86,029,000 $ 11,524,000
Unrealized Gain/(Loss) (3,525,000) 3,851,000
Fair Value 82,504,000 15,375,000
Cash and Cash Equivalents 65,645,000 5,183,000
Current Marketable Securities 7,319,000 9,136,000
Investments 9,540,000 1,056,000
Fair Value, Inputs, Level 2 [Member] | Warrant [Member]    
Compensating Balances [Line Items]    
Adjusted Cost 15,657,000 700,000
Unrealized Gain/(Loss) (6,117,000) 356,000
Fair Value 9,540,000 1,056,000
Cash and Cash Equivalents
Current Marketable Securities
Investments 9,540,000 1,056,000
Cash and Cash Equivalents [Member]    
Compensating Balances [Line Items]    
Adjusted Cost 6,497,000 1,690,000
Unrealized Gain/(Loss)
Fair Value 6,497,000 1,690,000
Cash and Cash Equivalents 6,497,000 1,690,000
Current Marketable Securities
Investments
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Compensating Balances [Line Items]    
Adjusted Cost 59,148,000 3,493,000
Unrealized Gain/(Loss)
Fair Value 59,148,000 3,493,000
Cash and Cash Equivalents 59,148,000 3,493,000
Current Marketable Securities
Investments
Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Compensating Balances [Line Items]    
Adjusted Cost 4,727,000 5,641,000
Unrealized Gain/(Loss) 2,592,000 3,495,000
Fair Value 7,319,000 9,136,000
Cash and Cash Equivalents
Current Marketable Securities 7,319,000 9,136,000
Investments
Cash Equivalents [Member]    
Compensating Balances [Line Items]    
Cash and Cash Equivalents $ 65,645,000 $ 5,183,000